Brown Brothers Harriman & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Brown Brothers Harriman & Co’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Buy	672 +538	+401%	+$72.7K	﹤0.01%	980
2026 Q1	$17.1K	Sell	134 -4,905	-97%	-$612K	﹤0.01%	1252
2025 Q4	$614K	Hold	5,039	–	–	﹤0.01%	482
2025 Q3	$505K	Hold	5,039	–	–	﹤0.01%	481
2025 Q2	$418K	Buy	5,039 +134	+3%	+$10.7K	﹤0.01%	490
2025 Q1	$398K	Hold	4,905	–	–	﹤0.01%	434
2024 Q4	$442K	Hold	4,905	–	–	﹤0.01%	427
2024 Q3	$485K	Hold	4,905	–	–	﹤0.01%	408
2024 Q2	$455K	Hold	4,905	–	–	﹤0.01%	391
2024 Q1	$465K	Hold	4,905	–	–	﹤0.01%	368
2023 Q4	$438K	Hold	4,905	–	–	﹤0.01%	368
2023 Q3	$358K	Hold	4,905	–	–	﹤0.01%	387
2023 Q2	$408K	Hold	4,905	–	–	﹤0.01%	357
2023 Q1	$374K	Hold	4,905	–	–	﹤0.01%	381
2022 Q4	$407K	Hold	4,905	–	–	﹤0.01%	346
2022 Q3	$389K	Hold	4,905	–	–	﹤0.01%	342
2022 Q2	$364K	Buy	4,905 +2,700	+122%	+$203K	﹤0.01%	364
2022 Q1	$198K	Buy	+2,205	New	+$204K	﹤0.01%	510
2020 Q1	–	Sell	-83	Closed	-$8K	–	1319
2019 Q4	$8K	Sell	83 -83	-50%	-$7.18K	﹤0.01%	922
2019 Q3	$13K	Buy	+166	New	+$13.8K	﹤0.01%	857
2018 Q4	–	Sell	-90	Closed	-$9K	–	1003
2018 Q3	$9K	Buy	+90	New	+$8.73K	﹤0.01%	696

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Brown Brothers Harriman & Co's XBI Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its State Street SPDR S&P Biotech ETF (XBI) stake by 401% in Q2 2026, buying an estimated $72.7K and bringing the position to 672 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Brown Brothers Harriman & Co first reported a position in XBI in Q3 2018 and has held it in 21 quarters since. The position peaked at $614K in Q4 2025. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Brown Brothers Harriman & Co held 672 shares of State Street SPDR S&P Biotech ETF worth $106K as of Q2 2026.
Brown Brothers Harriman & Co bought 538 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $72.7K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #980 holding.
Brown Brothers Harriman & Co first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 21 quarters since.
Brown Brothers Harriman & Co's State Street SPDR S&P Biotech ETF position peaked at $614K in Q4 2025.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.